Litigation Details for Wilder v. Allergan Inc. (S.D.N.Y. 2020)
✉ Email this page to a colleague
Wilder v. Allergan Inc. (S.D.N.Y. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-08-21 |
Court | District Court, S.D. New York | Date Terminated | |
Cause | Assigned To | Lewis Jeffrey Liman | |
Jury Demand | Referred To | ||
Patents | 6,545,040 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Wilder v. Allergan Inc.
Details for Wilder v. Allergan Inc. (S.D.N.Y. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-08-21 | 1 | Complaint | them of allegedly infringing U.S. Patent No. 6,545,040 (the “’040 Patent”), which Forest successfully submitted…name.” The ’362 Patent was prior art to the ’040 Patent. In light of the ’362 Patent’s essentially explicit…expiry of the only other patent that Forest contended covered Bystolic, U.S. Patent No. 5,759,580 (the “’… Forest’s patent settlement agreements with the Generic Competitors in the Bystolic patent litigation…the ’040 Patent, Bystolic would have no generic competitors and Forest would maintain patent-generated | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |